股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 中國人民保險集團股份有限公司 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01339 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 8,726,234,000 | RMB | | 1 RMB | | 8,726,234,000 | | 增加 / 減少 (-) | | | 0 | | | RMB | | 0 | | 本月底結存 | | | 8,726,234,000 | RMB | | 1 RMB | | 8,726,234,000 | | 2. 股份分類 | 普通股 | 股份類 ...

中国经济网北京1月5日讯 国家金融监督管理总局网站昨日公布的遵义监管分局行政处罚信息公开表 （遵金罚决字〔2025〕40-45号）显示，中国人民财产保险股份有限公司遵义市播州区支公司虚列业务 宣传费用，中国人民财产保险股份有限公司遵义市汇川区支公司虚挂中介业务套取手续费。 时任中国人民财产保险股份有限公司遵义市播州区支公司经理杨江玉、时任中国人民财产保险股份有限 公司遵义市播州区支公司综合部经理邓丽对中国人民财产保险股份有限公司遵义市播州区支公司上述违 法违规行为负有责任。 时任中国人民财产保险股份有限公司遵义市汇川区支公司经理申讯、时任中国人民财产保险股份有限公 司遵义市汇川区支公司直销团队经理万启兵对中国人民财产保险股份有限公司遵义市汇川区支公司上述 违法违规行为负有责任。 | 序 | | 行政处罚决 | 主要违法 | 行政处 | 作出 | | --- | --- | --- | --- | --- | --- | | 를 | 当事人名称 | 定书文号 | 违规行为 | 罚内容 | 决定 | | | | | | | 机关 | | | 中国人民财产 保险股份有限 | 做共同决字 (2025) 40 | | ...

从资金流向上来看，当日保险板块主力资金净流入15.19亿元，游资资金净流出3.75亿元，散户资金净流 出11.44亿元。保险板块个股资金流向见下表： 证券之星消息，1月5日保险板块较上一交易日上涨6.24%，新华保险领涨。当日上证指数报收于 4023.42，上涨1.38%。深证成指报收于13828.63，上涨2.24%。保险板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 601336 | 新华保险 | 75.88 | 8.87% | 39.38万 | | 29.19 Z | | 601601 | 中国太保 | 45.06 | 7.52% | 66.26万 | | 29.28 乙 | | 601628 | 中国人寿 | 48.27 | 6.09% | 28.86万 | | 13.69亿 | | 601318 | 中国平安 | 72.36 | 5.79% | 122.88万 | | 88.25 Z | | 601319 | 中国人保 | 9.43 | 5.36% ...

证券研究报告 固收定期报告 hyzqdatemark 2026 年 01 月 05 日 证券分析师 廖志明 SAC：S1350524100002 liaozhiming@huayuanstock.com 赵孟田 SAC：S1350525070004 zhaomengtian@huayuanstock.com 联系人 长端收益率走高，利差大多小幅收窄 ——信用分析周报（2025/12/29-2026/1/4） 投资要点： 本周信用热点事件：12 月 26 日"15 天安人寿"公告实质性违约。 本周市场概览： 1）一级市场：本周传统信用债发行量、偿还量、净融资额环比上周均有所减少；资 产支持证券净融资额环比上周减少 192 亿元。本周由于元旦节前整体发行量较少， 不同评级不同券种的平均发行利率较上周变化幅度相对较大。 2）二级市场：本周信用债成交量环比上周减少 8328 亿元；换手率方面，本周信用 债换手率较上周整体下行。本周 1Y 短端信用债收益率小幅下行，其余不同评级不同 期限的信用债收益率大多有所上行。总体来看，本周不同行业不同评级的信用利差 较上周波动幅度均不超过 5BP，且大多有所压缩。具体来看，本周 ...

截至月份: 2025年12月31日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 2. 股份分類 | 普通股 | A 股份類別 | | | 於香港聯交所上市 (註1) | | 否 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 601319 | 說明 | | 於上海證券交易所上市 | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 35,497,756,583 | RMB | | 1 RMB | | 35,497,756,583 | | 增加 / 減少 (-) | | | 0 | | | RMB | | 0 | | 本月底結存 | | | 35,497,756,583 | RMB | | 1 RMB | | 35,497,756,583 | 本月底法定/註冊股本總額： RMB 44,223,990,583 備註： 第 1 頁 共 11 頁 v 1.1.1 致：香港交易及結算所有限 ...

保险板块走强，新华保险、中国太保均涨超7%，股价齐创历史新高。 | 代码 名称 | 涨幅� 现价 | | --- | --- | | 601336 新华保险 | +8.87% 75.88 | | 601601 中国太保 | +7.52% 45.06 | | 601628 中国人寿 | +6.09% 48.27 | | 601318 中国平安 | +5.79% 72.36 | | 601319 中国人保 | +5.36% 9.43 | 沪深两市成交额高达2.55万亿，较上一个交易日放量5011亿。市场近4200股上涨，其中127只个股涨停。 | | | 第口财经 ---- 两市近5日成交额 (单位：亿元) 25462 21601 21393 21423 20451 12月30日 12月26日 12月29日 12月31日 1月5日 1月5日，A股主要指数集体高开后震荡走强，沪指时隔34个交易日重回4000点。截至收盘，沪指涨1.38%，深成指涨2.24%，创业板指涨 2.85%。科创综指涨3.61%。 | 代码 | 名称 | 两日图 | 现价 | 涨跌 | 涨跌幅 | | --- | --- | --- | -- ...

Core Viewpoint - The A-share market experienced a strong start in 2026, with the Shanghai Composite Index surpassing 4000 points and a notable increase in various sectors, particularly insurance, pharmaceuticals, and technology [2][6]. Group 1: Insurance Sector - The insurance sector saw significant gains, with major companies like New China Life and China Pacific Insurance reaching historical highs [4]. - Since Q3 2025, the insurance sector has been a stabilizing force in the market, benefiting from favorable policies such as the guidance on health insurance development and adjustments to risk factors for insurance companies [6]. - Looking ahead to 2026, the insurance sector is expected to maintain a competitive edge due to attractive returns on dividend insurance products and improvements in distribution channels, which may lead to positive growth in new business value (NBV) [7]. Group 2: Pharmaceutical Sector - The pharmaceutical sector experienced a broad rally, with significant increases in stocks of leading companies such as BeiGene and WuXi AppTec [9]. - In 2025, the number of approved innovative drugs reached 76, a 58.3% increase from 48 in 2024, marking a historical high [11]. - The outlook for 2026 is optimistic, with expectations that the innovative drug sector will dominate the pharmaceutical industry, supported by the integration of medical insurance and commercial insurance, which will enhance payment capabilities [13][14].

Market Overview - The A-share market saw a strong opening on January 5, with the Shanghai Composite Index returning to 4000 points, closing at 4011.45, up 1.07% [1] - The Shenzhen Component Index rose by 1.87%, and the ChiNext Index increased by 2.15% [1] Trading Volume - The total trading volume in the Shanghai and Shenzhen markets reached 1.64 trillion yuan, an increase of 323.8 billion yuan compared to the previous trading day [3] Stock Performance - A total of 4064 stocks rose, with 99 stocks hitting the daily limit, while 1236 stocks declined [3] - The sectors that performed well included insurance, medical devices, semiconductors, and gaming, with brain-computer interface concept stocks experiencing significant gains [3] Sector Highlights Brain-Computer Interface - Brain-computer interface stocks surged, with several companies hitting the daily limit [6] - Notable performers included Xiangyu Medical, Guanhao Biological, Meihua Medical, Aipeng Medical, and Lepu Medical, all recording a 20% increase [6][7] - Elon Musk's Neuralink announced plans for large-scale production of brain-computer interface devices by December 31, 2026, which is expected to revolutionize the field by reducing invasiveness [9] Semiconductor Sector - The semiconductor sector also showed strength, with multiple stocks reaching their daily limit [10] - Key performers included Dongwei Semiconductor and *ST Tianlong, both achieving a 20% increase [11] - TSMC announced it received U.S. government approval to import chip manufacturing equipment to its Nanjing facility in 2026, which is a positive development for the sector [12] Insurance Sector - The insurance sector experienced a rally, with significant gains from major companies [13] - Xinhua Insurance rose by 7.53%, China Pacific Insurance by 6.16%, and China Life Insurance by over 5% [13][14] - The insurance industry reported a total premium income of 57.629 billion yuan for the first 11 months of 2025, a year-on-year increase of 7.6% [14]

Core Viewpoint - The insurance sector has shown strong performance, with significant stock price increases, particularly for New China Life Insurance, which reached a historical high, indicating a robust market outlook for 2025 and beyond [2][3]. Group 1: Stock Performance - The insurance sector rose by 5.84%, with New China Life Insurance (601336) leading with a 7.53% increase, marking a historical high [2]. - Other major players such as China Ping An (601318), China Pacific Insurance (601601), China Life Insurance (601628), and China Reinsurance (601319) also saw increases exceeding 4% [2]. - Year-to-date performance for 2025 shows New China Life Insurance up by 40.24%, China Ping An by 29.91%, China Pacific Insurance by 22.98%, China Reinsurance by 17.45%, and China Life Insurance by 8.54% [3]. Group 2: Premium Income and Market Dynamics - In the first 11 months of the year, the insurance industry achieved a total premium income of 57,629 billion yuan, reflecting a year-on-year growth of 7.6% [3]. - Life insurance companies contributed 41,472 billion yuan with a growth of 9.1%, while property insurance companies reported 16,157 billion yuan, growing by 3.9% [3]. Group 3: Investment and Regulatory Environment - Analysts highlight that regulatory support is encouraging insurance companies to increase equity allocations, with various financial authorities guiding insurance capital into the market [3]. - The demand for equity assets is rising due to low interest rates and asset scarcity, leading to increased pressure on insurance companies to enhance their equity investment capabilities [3]. - It is projected that approximately 600 billion yuan of new insurance funds will enter the market by 2026 [3]. Group 4: Future Outlook - Analysts expect the insurance sector to maintain strong performance due to improving conditions on both the asset and liability sides, with a focus on optimizing liability costs and enhancing investment returns [4]. - The market demand remains robust, and adjustments in interest rates and product offerings are anticipated to alleviate pressure on profit margins [4]. - Current valuations of insurance stocks are considered low, suggesting significant upside potential as the market continues to recover [4].

2026年A股开市了！首个交易日，三大指数早盘集体上涨，上证指数盘中重回4000点。盘面热点快速轮 动，脑机接口板块掀起涨停潮，倍益康"30cm"涨停，三博脑科等超20只个股涨停。保险板块表现活 跃，中国太保、新华保险盘中双双创历史新高。商业航天板块延续强势，金风科技等近20只个股封板。 此外，创新药、有色金属、游戏等板块盘中均表现积极。 您觉得哪个板块能成为2026年首周A股最热赛道？ 人脑工程板块掀涨停潮 创新药概念飙升 截至今日午间休市，沪指涨1.07%，深证成指涨1.87%，创业板指涨2.15%，沪深北三市半日成交16489 亿元，较上个交易日同期放量3240亿元。全市场超4000只个股上涨。人脑工程板块掀涨停潮，博拓生 物、熵基科技、三博脑科等10余只个股"20cm"涨停。 消息面上，埃隆·马斯克2025年12月31日在社交媒体上表示，其脑机接口公司"神经连接"（Neuralink） 将于2026年开始对脑机接口设备进行"大规模生产"，并转向"更加精简和几乎完全自动化的外科手术流 程"。（详见马斯克发声！301293，开盘"20cm"涨停） 开源证券最新研报表示，上述行业事件印证了脑机接口技术预计将 ...